(Q35588198)

9 August 2017

1 reference

title

Differential pricing for pharmaceuticals: reconciling access, R&D and patents (English)

1 reference

9 August 2017

0 references

Patricia M Danzon

1

1 reference

9 August 2017

Adrian Towse

series ordinal

2

1 reference

9 August 2017

language of work or name

1 reference

1 September 2003

1 reference

International Journal of Health Care Finance and Economics

9 August 2017

published in

1 reference

9 August 2017

volume

3

1 reference

9 August 2017

issue

3

1 reference

9 August 2017

page(s)

183-205

1 reference

Cost of innovation in the pharmaceutical industry

9 August 2017

cites work

1 reference

https://pubmed.ncbi.nlm.nih.gov/14625999

PubMed

reference URL

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The price of innovation: new estimates of drug development costs

1 reference

https://pubmed.ncbi.nlm.nih.gov/14625999

PubMed

reference URL

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The impact of price regulation on the launch delay of new drugs--evidence from twenty-five major markets in the 1990s

1 reference

https://pubmed.ncbi.nlm.nih.gov/14625999

PubMed

reference URL

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1023/A:1025384819575

1 reference

Dimensions Publication ID

9 August 2017

1018272010

0 references

1 reference